Table 1.
Summary of 8 cases of the stomachdesmoid tumors
| NO. | Sex | Age (year) | Symptoms | Tumor location | Tumor size (mm) | Ultrasonography and endoscopy findings | Surgical resection | Adjuvant therapy | Immunohistochemistry | Recurrence | Follow-up |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 47 | Upper abdominal pain | The posterior wall of the antrum | 45 × 35 × 40 | Ulcer lesions, ultrasonography hypoechoic mass with less clear boundaries | R1 | No | Positive: SMA, β-catenin | No | ANED |
| Negative: CD117, CD34, S100 | |||||||||||
| 2 | M | 45 | Abdominal pain, hematemesis | The posterior wall of the gastric body | 68 × 52 | Irregular mucosal uplift, surface deep ulcers, no ultrasonography description | R0/R1 | NA | Positive: SMA, S100, β-catenin | NA | NA |
| Negative: CD117, Des, CD34 | |||||||||||
| 3 | F | 42 | Abdominal discomfort | Greater curvature of the stomach | 70 × 70 × 60 | Submucosal tumor, ulcer lesions, ultrasonography hypoechoic mass with clear boundaries | R0/R1 | NA | Positive: - | NA | NA |
| Negative: SMA, CD34, CD117 | |||||||||||
| 4 | M | 28 | Dysphagia, vomiting | Gastroesophageal junction | 50 × 18 | Mucosal erosion, ultrasonography hypoechoic mass with less clear boundaries | R0/R1 | Radiotherapy | Positive: SMA, CD117 (dot +) | No | ANED |
| Negative: S100, CD34 | |||||||||||
| 5 [20] | M | 9 | Abdominal pain, vomiting | Gastroesophageal junction | NA | diffuse gastric wall thickening in ultrasonography, endoscopy did not pass the cardia | R0 | No | Positive: - | No | ANED |
| Negative: S100, CD34, Des | |||||||||||
| 6 [13] | M | 67 | NA | The posterior wall of the stomach | NA | NA | NA | Chemotherapy | NA | NA | AWD |
| 7 [21] | F | 15 | NA | Gastroesophageal junction | NA | NA | NA | NA | NA | NA | NA |
| 8 [22] | M | 56 | NA | The remaining greater curvature of the stomach | 40 × 40 | submucosal tumor, ultrasonography hypoechoic mass with clear boundaries | R0/R1 | Positive: β-catenin | No | ANED | |
| Negative: - |
Notes: NA: not available; ANED: alive with no evidence of disease; AWD: alive with disease; No. 8 underwent early gastric distal gastrectomy 18 months ago; No. 1 follow-up 63 months; No. 4 follow-up 22 months; No. 5 follow-up 12 months; No. 8 follow-up 12 months.